Somatostatin Analog [EPC] - N0000175904

Pharmacologic Class Information

Pharmacologic Code N0000175904
Pharmacologic Name Somatostatin Analog
Pharmacologic Uses
  • somatostatin analog
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Somatostatin Analog

The table contains 42 products whose active ingredient are classified under the same pharmacologic class Somatostatin Analog [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0078-0180Sandostatin Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousNovartis Pharmaceuticals CorporationACTIVE
0078-0181Sandostatin Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousNovartis Pharmaceuticals CorporationACTIVE
0078-0182Sandostatin Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousNovartis Pharmaceuticals CorporationACTIVE
0641-6174Octreotide Acetate Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHikma Pharmaceuticals Usa Inc.ACTIVE
0641-6175Octreotide Acetate Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHikma Pharmaceuticals Usa Inc.ACTIVE
0641-6176Octreotide Acetate Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHikma Pharmaceuticals Usa Inc.ACTIVE
0641-6177Octreotide Acetate Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHikma Pharmaceuticals Usa Inc.ACTIVE
0641-6178Octreotide Acetate Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHikma Pharmaceuticals Usa Inc.ACTIVE
15054-1060Somatuline Depot Non-Proprietary Name: Lanreotide AcetateInjectionSubcutaneousIpsen Biopharmaceuticals, Inc.ACTIVE
15054-1090Somatuline Depot Non-Proprietary Name: Lanreotide AcetateInjectionSubcutaneousIpsen Biopharmaceuticals, Inc.ACTIVE
15054-1120Somatuline Depot Non-Proprietary Name: Lanreotide AcetateInjectionSubcutaneousIpsen Biopharmaceuticals, Inc.ACTIVE
23155-685Octreotide Acetate Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHeritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.ACTIVE
23155-686Octreotide Acetate Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHeritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.ACTIVE
23155-687Octreotide Acetate Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHeritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.ACTIVE
23155-688Octreotide Acetate Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHeritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.ACTIVE
23155-689Octreotide Acetate Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHeritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.ACTIVE
25021-463Octreotide Acetate Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousSagent PharmaceuticalsACTIVE
25021-464Octreotide Acetate Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousSagent PharmaceuticalsACTIVE
25021-465Octreotide Acetate Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousSagent PharmaceuticalsACTIVE
25021-466Octreotide Acetate Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousSagent PharmaceuticalsACTIVE
25021-467Octreotide Acetate Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousSagent PharmaceuticalsACTIVE
55292-131Signifor Non-Proprietary Name: PasireotideInjectionSubcutaneousRecordati Rare Diseases, Inc.ACTIVE
55292-132Signifor Non-Proprietary Name: PasireotideInjectionSubcutaneousRecordati Rare Diseases, Inc.ACTIVE
55292-133Signifor Non-Proprietary Name: PasireotideInjectionSubcutaneousRecordati Rare Diseases, Inc.ACTIVE
63323-376Octreotide Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcACTIVE
63323-377Octreotide Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcACTIVE
63323-378Octreotide Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcACTIVE
63323-379Octreotide Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcACTIVE
63629-8831Octreotide Acetate Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousBryant Ranch PrepackACTIVE
67457-239Octreotide Acetate Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousMylan Institutional LlcACTIVE
67457-245Octreotide Acetate Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousMylan Institutional LlcACTIVE
67457-246Octreotide Acetate Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousMylan Institutional LlcACTIVE
68083-515Octreotide Acetate Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousGland Pharma LimitedACTIVE
68083-516Octreotide Acetate Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousGland Pharma LimitedACTIVE
68083-517Octreotide Acetate Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousGland Pharma LimitedACTIVE
68083-560Octreotide Acetate Non-Proprietary Name: Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousGland Pharma LimitedACTIVE
69097-870Lanreotide Acetate Non-Proprietary Name: Lanreotide AcetateInjectionSubcutaneousCipla Usa Inc.ACTIVE
69097-880Lanreotide Acetate Non-Proprietary Name: Lanreotide AcetateInjectionSubcutaneousCipla Usa Inc.ACTIVE
69097-890Lanreotide Acetate Non-Proprietary Name: Lanreotide AcetateInjectionSubcutaneousCipla Usa Inc.ACTIVE
69880-120Mycapssa Non-Proprietary Name: OctreotideCapsule, Delayed ReleaseOralAmryt Pharmaceuticals Designated Activity CompanyACTIVE